Cyltezo

Generic Name: cyltezo

Over-the-Counter (OTC)

Dosage form: LIQUID. Active ingredients: ADALIMUMAB (50 mg/50mg). Category: BULK INGREDIENT.

Overview

Dosage form: LIQUID. Active ingredients: ADALIMUMAB (50 mg/50mg). Category: BULK INGREDIENT.

Dosage

Available as liquid.

Related Medications

Ear/eye/sinus Drops

ear/eye/sinus drops

Non-Standardized Plant Allergenic Extract [EPC]

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Alternaria Tenuis, Aspergillus Mixture, Botrytis Cinerea, Chaetomium Globosum, Cladosporium Cladosporioides, Curvularia, Epicoccum Nigrum, Fusarium Vasinfectum, Mucor Racemosus, Neurospora, Nigrospora, Penicillium Mixture, Phoma Herbarum, Pullularia Pullulans, Rhizopus, Rhodotorula, Stemphylium, Trichoderma Lignorum, Trichophyton Mentagrophytes, Baptisia Tinctoria, Hydrastis Canadensis, Myrrha, Nasturtium Aquaticum, Phytolacca Decandra, Trigonella Foenum-graecum, Echinacea

alternaria tenuis, aspergillus mixture, botrytis cinerea, chaetomium globosum, cladosporium cladosporioides, curvularia, epicoccum nigrum, fusarium vasinfectum, mucor racemosus, neurospora, nigrospora, penicillium mixture, phoma herbarum, pullularia pullulans, rhizopus, rhodotorula, stemphylium, trichoderma lignorum, trichophyton mentagrophytes, baptisia tinctoria, hydrastis canadensis, myrrha, nasturtium aquaticum, phytolacca decandra, trigonella foenum-graecum, echinacea

Non-Standardized Fungal Allergenic Extract [EPC]

Purpose: Relief from Sneezing, Runny Nose, Itchy Eyes and Sinus Congestion.*

Faricimab

faricimab

11 DESCRIPTION Faricimab-svoa is a humanized bispecific immunoglobulin G1 (IgG1) antibody that binds both vascular endothelial growth factor A (VEGF-A) and angiopoietin-2 (Ang-2). The fragment crystallizable (Fc) region of faricimab was engineered by selected point mutations to abolish binding interactions with Fcγ and FcRn receptors.

Medical Disclaimer

This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.